Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Celogics logo — Quality Cells, Quality Research. Providing iPSC differentiat...

Celogics

Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutical research

Founded 2021 United States Seattle, United States 3 employees Biotechnology, Manufacturing

General Information

Company Name Celogics
Founded Year 2021
Location United States Seattle, United States +1
Employees 3
Industries Biotechnology, Manufacturing
Social

Get notified when Celogics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Celogics

Celogics, founded in 2021, is carving a niche in the biotechnology and manufacturing sectors by pioneering advanced iPSC differentiation services tailored for pharmaceutical research. With the mission of enhancing the quality of human cell culture, Celogics aims to revolutionize research by producing the highest quality iPSC-derived cells, branded under Celo.Cells.

The company is a joint venture between Curi Bio and NEXEL, leveraging this partnership to drive innovation in drug discovery, safety screening, and disease modeling. The establishment of a 22,000 square feet facility marks a significant step toward becoming the premier supplier of functional cell models.

While investment information is currently unavailable, the burgeoning interest in next-generation cell models positions Celogics as a promising opportunity for future investors seeking to impact the evolving landscape of pharmaceutical research.

Taxonomy: iPSC differentiation, pharmaceutical research, human cell culture, research-use-only cell products, drug discovery, drug safety screening, disease modeling, iPSC-derived cells, life sciences, functional cell models, Celo.Cells brand, biotechnology joint venture, cell manufacturing, validated data provision, cell model innovation

Services & Products

Custom Cardiomyocytes Development
High-Quality Human iPSC-derived Cell Products
Drug Development Acceleration
Disease Modeling Research

Target Customers

Pharmaceutical Companies Biotech Researchers Medical Research Institutions Disease Modelers

No funding data available for Celogics yet.

Get notified when Celogics raises funding

Celogics Alternatives & Competitors

View All Alternatives
Celogics vs
Axol Bioscience Ltd.
Axol Bioscience Ltd. United Kingdom

Better Human Disease Models

Series Unknown
49 employees
Biopharma, Biotechnology
Compare Celogics vs Axol Bioscience Ltd.
Celogics vs
ImStem Biotechnology, Inc
ImStem Biotechnology, Inc United States

Imstem Biotechnology, Inc. is a biotechnology company focusing on developing cell therapeutic produc...

Grant
11 employees
Biotechnology, Health Care
Celogics vs
REPROCELL
REPROCELL Japan

Better Translating Discoveries into Therapies

Unknown
58 employees
Biotechnology
View all alternatives

FAQ About Celogics

Quality Cells, Quality Research. Providing iPSC differentiation services for pharmaceutical research
Celogics was founded in 2021.
Celogics is headquartered in Seattle, United States.
Celogics operates in the following industries: Biotechnology, Manufacturing.
Celogics has approximately 3 employees.
Celogics offers: Custom Cardiomyocytes Development, High-Quality Human iPSC-derived Cell Products, Drug Development Acceleration, Disease Modeling Research.
Top alternatives and competitors to Celogics include Axol Bioscience Ltd., ImStem Biotechnology, Inc, REPROCELL, FUJIFILM Cellular Dynamics, Inc, StemoniX. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Celogics and Axol Bioscience Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Celogics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy